Analysts: The Clorox Co (CLX.N)
CLX.N on New York Stock Exchange
84.83USD
1 Aug 2013
84.83USD
1 Aug 2013
Price Change (% chg)
$-1.11 (-1.29%)
$-1.11 (-1.29%)
Prev Close
$85.94
$85.94
Open
$86.70
$86.70
Day's High
$86.91
$86.91
Day's Low
$84.38
$84.38
Volume
471,064
471,064
Avg. Vol
235,997
235,997
52-wk High
$90.09
$90.09
52-wk Low
$69.71
$69.71
Consensus Recommendations
| Consensus Recommendation | Next Earnings (approx.) | Company Fiscal Year End Month |
Last Updated |
|---|---|---|---|
| Hold | 1.07 | June | 1 Aug 2013 |
Analyst Recommendations and Revisions
| 1-5 Linear Scale | Current | 1 Month Ago |
2 Month Ago |
3 Month Ago |
|---|---|---|---|---|
| (1) BUY | 2 | 1 | 1 | 1 |
| (2) OUTPERFORM | 1 | 1 | 1 | 2 |
| (3) HOLD | 14 | 16 | 16 | 14 |
| (4) UNDERPERFORM | 1 | 1 | 1 | 1 |
| (5) SELL | 0 | 0 | 0 | 0 |
| No Opinion | 0 | 0 | 0 | 0 |
| Mean Rating | 2.78 | 2.89 | 2.89 | 2.83 |
Consensus Estimates Analysis
Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
| # of Estimates | Mean | High | Low | 1 Year Ago |
|
|---|---|---|---|---|---|
| SALES (in millions) | |||||
| Quarter Ending Sep-13 | 9 | 1,384.18 | 1,407.40 | 1,359.82 | 1,405.68 |
| Quarter Ending Dec-13 | 9 | 1,340.02 | 1,372.70 | 1,305.60 | 1,306.85 |
| Year Ending Jun-13 | 15 | 5,654.18 | 5,710.30 | 5,632.30 | 5,664.48 |
| Year Ending Jun-14 | 16 | 5,827.97 | 5,960.00 | 5,697.88 | 5,853.23 |
| Earnings (per share) | |||||
| Quarter Ending Sep-13 | 15 | 1.07 | 1.11 | 1.01 | 1.06 |
| Quarter Ending Dec-13 | 15 | 0.98 | 1.04 | 0.91 | 0.88 |
| Year Ending Jun-13 | 18 | 4.29 | 4.35 | 4.24 | 4.27 |
| Year Ending Jun-14 | 19 | 4.62 | 4.75 | 4.55 | 4.60 |
| LT Growth Rate (%) | 2 | 7.15 | 7.30 | 7.00 | 6.68 |
Historical Surprises
Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
| Estimates vs Actual | Estimate | Actual | Difference | Surprise % |
|---|---|---|---|---|
| SALES (in millions) | ||||
| Quarter Ending Mar-13 | 1,435.03 | 1,413.00 | 22.03 | 1.54 |
| Quarter Ending Dec-12 | 1,270.45 | 1,325.00 | 54.55 | 4.29 |
| Quarter Ending Sep-12 | 1,353.30 | 1,338.00 | 15.30 | 1.13 |
| Quarter Ending Jun-12 | 1,532.56 | 1,541.00 | 8.44 | 0.55 |
| Quarter Ending Mar-12 | 1,352.32 | 1,401.00 | 48.68 | 3.60 |
| Earnings (per share) | ||||
| Quarter Ending Mar-13 | 1.05 | 1.00 | 0.05 | 4.82 |
| Quarter Ending Dec-12 | 0.81 | 0.93 | 0.12 | 15.31 |
| Quarter Ending Sep-12 | 0.95 | 1.01 | 0.06 | 5.89 |
| Quarter Ending Jun-12 | 1.27 | 1.32 | 0.05 | 4.08 |
| Quarter Ending Mar-12 | 1.03 | 1.02 | 0.01 | 1.03 |
Consensus Estimates Trend
Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
| Current | 1 Week Ago |
1 Month Ago |
2 Month Ago |
1 Year Ago |
|
|---|---|---|---|---|---|
| SALES (in millions) | |||||
| Quarter Ending Sep-13 | 1,384.18 | 1,384.18 | 1,387.81 | 1,388.63 | 1,405.68 |
| Quarter Ending Dec-13 | 1,340.02 | 1,340.02 | 1,338.18 | 1,339.03 | 1,306.85 |
| Year Ending Jun-13 | 5,654.18 | 5,650.18 | 5,653.52 | 5,654.48 | 5,664.48 |
| Year Ending Jun-14 | 5,827.97 | 5,827.97 | 5,835.32 | 5,839.57 | 5,853.23 |
| Earnings (per share) | |||||
| Quarter Ending Sep-13 | 1.07 | 1.07 | 1.07 | 1.07 | 1.06 |
| Quarter Ending Dec-13 | 0.98 | 0.98 | 0.97 | 0.98 | 0.88 |
| Quarter Ending Jun-13 | 4.29 | 4.29 | 4.29 | 4.30 | 4.27 |
| Quarter Ending Jun-14 | 4.62 | 4.62 | 4.62 | 4.63 | 4.60 |
Estimates Revisions Summary
| Last Week | Last 4 Weeks | |||
|---|---|---|---|---|
| Number Of Revisions: | Up | Down | Up | Down |
| Revenue | ||||
| Quarter Ending Sep-13 | 0 | 0 | 1 | 0 |
| Quarter Ending Dec-13 | 0 | 0 | 1 | 0 |
| Year Ending Jun-13 | 0 | 0 | 1 | 2 |
| Year Ending Jun-14 | 0 | 0 | 0 | 3 |
| Earnings | ||||
| Quarter Ending Sep-13 | 0 | 0 | 1 | 2 |
| Quarter Ending Dec-13 | 0 | 0 | 0 | 2 |
| Year Ending Jun-13 | 0 | 0 | 0 | 2 |
| Year Ending Jun-14 | 0 | 0 | 1 | 2 |
Analyst Research Reports
| Report Title | Price |
|---|---|
|
Provider: Thomson Reuters Stock Report
|
$25.00
|
|
Provider: ValuEngine, Inc.
|
$25.00
|
|
Trading Report for (CLX). A detailed report, including free correlated market analysis, and updates.
Provider: Stock Traders Daily
|
$58.00
|
|
Provider: Stock Traders Daily
|
$495.00
|
|
Provider: S&P Capital IQ – STARS Reports
|
$127.00
|
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Earnings vs.
Estimates